Michael DesJardin
Chief Tech/Sci/R&D Officer en HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY .
Perfil
En la actualidad, Michael A. DesJardin ocupa el cargo de Vicepresidente Ejecutivo de Operaciones Técnicas y Calidad en Horizon Therapeutics Plc y Vicepresidente Senior de Operaciones Técnicas en Horizon Pharmaceutical LLC (una filial de Horizon Therapeutics Plc). También es Vicepresidente Senior de Operaciones Técnicas en Horizon Pharmaceutical LLC. Anteriormente, ocupó el cargo de Vicepresidente Senior de Desarrollo de Productos en Jazz Pharmaceuticals Plc y de Director Ejecutivo de Investigación y Desarrollo de Implantes en ALZA Corp. El Sr. DesJardin se licenció en la Universidad de California, Berkeley.
Cargos activos de Michael DesJardin
Empresas | Cargo | Inicio |
---|---|---|
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Chief Tech/Sci/R&D Officer | 01/02/2017 |
Antiguos cargos conocidos de Michael DesJardin.
Empresas | Cargo | Fin |
---|---|---|
RAPTOR PHARMACEUTICAL CORP | Chief Tech/Sci/R&D Officer | 01/10/2016 |
JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 01/03/2015 |
ALZA CORPORATION | Chief Tech/Sci/R&D Officer | - |
Formación de Michael DesJardin.
University of California, Berkeley | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
JAZZ PHARMACEUTICALS PLC | Health Technology |
Empresas privadas | 3 |
---|---|
ALZA Corp.
ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Horizon Therapeutics Plc
Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Horizon Pharmaceutical LLC
Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Horizon Pharmaceutical LLC engages in the development of transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel on April 29, 2002 and is headquartered in Novato, CA. | Health Technology |